Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| 1 |
Microsoft
MSFT
|
+$1.75B |
| 2 |
NVIDIA
NVDA
|
+$1.34B |
| 3 |
Capital One
COF
|
+$1.16B |
| 4 |
Apple
AAPL
|
+$1.01B |
| 5 |
Amazon
AMZN
|
+$813M |
Top Sells
| 1 |
DFS
Discover Financial Services
DFS
|
+$1.09B |
| 2 |
Palantir
PLTR
|
+$777M |
| 3 |
Coca-Cola
KO
|
+$496M |
| 4 |
Qualcomm
QCOM
|
+$469M |
| 5 |
Applovin
APP
|
+$390M |
Sector Composition
| 1 | Technology | 32.48% |
| 2 | Financials | 14.03% |
| 3 | Consumer Discretionary | 10.52% |
| 4 | Healthcare | 9.35% |
| 5 | Communication Services | 9.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
DMAA
3576
Drugs Made In America Acquisition Corp. Ordinary Shares
DMAA
$345M
| $466K | ﹤0.01% |
45,648
+186
| +0.4% | +$1.9K |
|
3577
Atara Biotherapeutics
ATRA
$85.5M
| $464K | ﹤0.01% |
60,136
+1,457
| +2% | +$11.3K |
|
3578
FiscalNote
NOTE
$67.9M
| $463K | ﹤0.01% |
71,906
-78,201
| -52% | -$504K |
|
3579
Actinium Pharmaceuticals
ATNM
$49.9M
| $462K | ﹤0.01% |
329,689
-382,112
| -54% | -$535K |
|
3580
Franklin Wireless
FKWL
$48.2M
| $461K | ﹤0.01% |
110,295
-658
| -0.6% | -$2.75K |
|
3581
Alpha Pro Tech
APT
$51.2M
| $460K | ﹤0.01% |
98,126
+715
| +0.7% | +$3.35K |
|
3582
Acumen Pharmaceuticals
ABOS
$87.2M
| $460K | ﹤0.01% |
396,626
-465,273
| -54% | -$540K |
|
3583
PMV Pharmaceuticals
PMVP
$84.8M
| $459K | ﹤0.01% |
432,704
+1,912
| +0.4% | +$2.03K |
|
3584
OptimumBank Holdings
OPHC
$49.9M
| $458K | ﹤0.01% |
102,355
+2,036
| +2% | +$9.1K |
|
3585
John Wiley & Sons Class B
WLYB
$2.1B
| $458K | ﹤0.01% |
10,131
+23
| +0.2% | +$1.04K |
|
3586
American Realty Investors
ARL
$260M
| $457K | ﹤0.01% |
32,381
-1,544
| -5% | -$21.8K |
|
3587
Vivani Medical
VANI
$75.8M
| $457K | ﹤0.01% |
353,898
-6,628
| -2% | -$8.55K |
|
3588
Invivyd
IVVD
$255M
| $456K | ﹤0.01% |
636,958
-988,696
| -61% | -$707K |
|
|
SBC
3589
SBC Medical Group Holdings Incorporated Common Stock
SBC
$512M
| $455K | ﹤0.01% |
+98,082
| New | +$455K |
|
3590
Purple Innovation
PRPL
$115M
| $453K | ﹤0.01% |
620,894
-754,631
| -55% | -$550K |
|
|
DQ
3591
Daqo New Energy
DQ
$1.86B
| $453K | ﹤0.01% |
29,841
-6,126
| -17% | -$92.9K |
|
3592
Culp
CULP
$57.4M
| $449K | ﹤0.01% |
114,344
+943
| +0.8% | +$3.71K |
|
3593
Stratasys
SSYS
$861M
| $447K | ﹤0.01% |
38,971
-56,763
| -59% | -$651K |
|
3594
United Homes Group
UHG
$246M
| $441K | ﹤0.01% |
152,144
-70,022
| -32% | -$203K |
|
|
EH
3595
EHang Holdings
EH
$1.18B
| $441K | ﹤0.01% |
25,409
-37,184
| -59% | -$646K |
|
3596
Fortress Biotech
FBIO
$107M
| $437K | ﹤0.01% |
234,790
-2,744
| -1% | -$5.1K |
|
3597
Metagenomi
MGX
$69.8M
| $434K | ﹤0.01% |
293,460
-326,114
| -53% | -$483K |
|
3598
First Seacoast Bancorp
FSEA
$54.8M
| $433K | ﹤0.01% |
38,263
+435
| +1% | +$4.92K |
|
3599
Mural Oncology
MURA
$36M
| $432K | ﹤0.01% |
174,761
-8,624
| -5% | -$21.3K |
|
3600
Adicet Bio
ACET
$66.9M
| $431K | ﹤0.01% |
706,334
-64,369
| -8% | -$39.3K |
|